Prostate Cancer Cells and Urokinase Receptor in Metastasis
Author Information
Author(s): Inder Sehgal, Timothy P. Foster, Joseph Francis
Primary Institution: Louisiana State University
Hypothesis
The study aims to compare uPAR expression in orthotopic vs. metastatic foci in vivo and examine how uPAR might promote early stages of metastasis.
Conclusion
The study provides evidence that elevated uPAR enhances resistance to anoikis in prostate cancer cells during metastasis.
Supporting Evidence
- uPAR staining is significantly greater in regional lymph node metastases than in the intraprostatic tumor mass.
- Transient over-expression of uPAR increases in vitro motility and chemotactic invasion.
- Prostate cancer cells with elevated uPAR show enhanced resistance to anoikis.
Takeaway
Prostate cancer cells can become more mobile and survive better when they have more of a protein called uPAR, which helps them spread to other parts of the body.
Methodology
The study used a mouse model to analyze uPAR expression in prostate cancer cells and assessed their motility and invasion in vitro.
Limitations
The study primarily focuses on a specific mouse model and may not fully represent human prostate cancer behavior.
Participant Demographics
Nude mice were used in the study.
Statistical Information
P-Value
0.0011
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website